ITDR MS-CETSA was conducted on MMV665941-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on MMV665987-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on MMV665806-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on MMV665909-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on pyronaridine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on amodiaquine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on lumefantrine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on MMV006656-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on MMV000848-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
ITDR MS-CETSA was conducted on piperaquine-treated live parasites and lysate of P. falciparum trophozoites in order to identify potential drug protein targets.
